|
|
 |
|
Viewing report
|
|
 |
AVI Biopharma, Inc.
Sheila Greco Associates, May 2011, Pages: 1
AVI BioPharma develops therapeutic products for the treatment of life?threatening diseases using third?generation NeuGene antisense drugs and ESPRIT exon skipping technology. AVI?s lead NeuGene antisense compound is designed to target cell proliferation d
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
 |
|
|